Evidence map›Paper›PMID 33330336›Full record

ArticleFrontiers in public health

Assessing the Severity of Illness in Patients With Coronavirus Disease in Saudi Arabia: A Retrospective Descriptive Cross-Sectional Study.

Abdulhadi M Alqahtani, Ziyad S AlMalki, Randah M Alalweet, Saja H Almazrou, Abdullah Salah Alanazi, Mona A Alanazi, Abdussalam A AlShehri, Saleh AlGhamdi

Abstract readComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Demographics, comorbidities, and outcomes among young and middle-aged COVID-19 patients in Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2021
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abdulhadi M AlqahtaniClinical Research Department, Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.
Ziyad S AlMalkiDepartment of Clinical Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia.
Randah M AlalweetPreventive Health - General Department of Infectious Diseases, Ministry of Health, Riyadh, Saudi Arabia.
Saja H AlmazrouDepartment of Clinical Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Abdullah Salah AlanaziDepartment of Clinical Pharmacy, Jouf University, Sakaka, Saudi Arabia.
Mona A AlanaziMedical Research Unit, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, Saudi Arabia.
Abdussalam A AlShehriMedical Research Unit, Prince Mohammed Bin Abdulaziz Hospital, Riyadh, Saudi Arabia.
Saleh AlGhamdiClinical Research Department, Research Center, King Fahad Medical City, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ComorbiditySeverity of Illness IndexAdultAgedAged, 80 and overAge FactorsCOVID-19Cross-Sectional StudiesDiabetes MellitusFemaleHumansHypertensionMaleMiddle AgedRetrospective StudiesRisk FactorscharacteristicsCOVID-19non-severeSaudi Arabiasevere

Identifiers

PMID33330336
PMCPMC7710861

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.